(A) Domains harbored by CD8lumenal. Predicted models of trans-interacting CD8lumenal preoteins that are expected to form lumenal staples. Predicted intra-lumenal space varies from 10 to 23 nm. (B) …
HeLa cells expressing CD8cytosolic were incubated without the disaggregating drug. Electron-micrograph showing that cytosolic staples trigger artificial stacking of ER membranes.
(A) Confocal micrograph showing HeLa cells expressing CD8lumenal in the presence or in the absence of the disaggregating drug. Without drug, ER-aggregated CD8lumenal remained at the ER (ER staples), …
HeLa cells expressing CD8lumenal were radiolabeled with 35S methionine for 30 min in the presence or the absence of the disaggregating drug (pulse). Then cells were washed and incubated at 20°C in …
(A) General procedure: 16°C temperature block and disaggregation/re-aggregation cycles are combined to form the staples in the cis-Golgi and assess the cisternal progression model. HeLa cells …
HeLa cells expressing CD8lumenal were incubated with the disaggregating drug at 16°C for 2 hr prior to being shifted at 37°C for 2 hr in the presence (1) or absence (2) of the drug. As negative …
(A) Confocal micrograph showing HeLa cells co-expressing DsRed-Golgin97, a trans-Golgi marker, with GFP-Golgin97 (upper panel) or Grasp65-GFP, a cis-Golgi marker (lower panel). Cis- and trans-Golgi …
HeLa cells expressing CD8lumenal were incubated at 16°C in the presence of the disaggregating drug for 2 hr, and then the drug was removed for 30 min, prior to shifting the temperature to 20°C for …
Similar to Figure 5 Hela cells expressing CD8lumenal were incubated at 16°C in the presence of the disaggregating drug for 2 hr, and then the drug was removed for 30 min, prior to shifting the …
HeLa cells co-expressing DsRed-CD8lumenal with VSVG-GFP were incubated overnight at 39°C in the absence of the disaggregating drug (1) prior to shifting the temperature to 16°C for 2 hr in the …
Saos-2 cells expressing GFP-CD8lumenal were incubated at 20°C for 1 hr in the presence of the disaggregating drug. When required Golgi staples were formed for 2 hr (2), prior to shifting the …
HeLa cells co-expressing ManII-DsRed and GFP-CD8lumenal were incubated at 20°C in the presence of the disaggregating drug for 1 hr. Then, when required, the drug was removed to promote staples …
HeLa cells expressing GFP-CD8lumenal were incubated in the absence of the disaggregating to keep the protein aggregated within the ER. FRAP was performed at 20°C (ER staples). As a negative control, …
HeLa cells co-expressing GFP-CD8lumenal and DsRed-hGH, both harboring the FM-aggregation domains, were incubated at 16°C for 2 hr in the presence of the disaggregating drug (3, negative control) …
HeLa cells co-expressing GFP-CD8lumenal or GFP-hGH, with DsRed-hGH, both harboring the FM-aggregation domains, were incubated overnight in the presence of the disaggregating drug (1) or in the …
HeLa cells co-expressing GFP-CD8lumenal and DsRed-hGH, both harboring the FM-aggregation domains, were incubated at 20°C for 2 hr in the presence of the disaggregating drug prior to shifting the …